Cidara Therapeutics, Inc.
NASDAQ: CDTX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jeffrey L. Stein
- Employees
- 38
- Headquarters
- San Diego, United States
- IPO year
- 2015
- Market cap
- $5.6B
- Website
- https://www.cidara.com
Loading CDTX…
Loading profile data…Frequently asked questions about CDTX
What does Cidara Therapeutics, Inc. (CDTX) do?
Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative ec...
Where does CDTX trade?
Cidara Therapeutics, Inc. (CDTX) trades on the NASDAQ Capital Market.
What sector is CDTX in?
Cidara Therapeutics, Inc. (CDTX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Cidara Therapeutics, Inc.?
Jeffrey L. Stein is the chief executive officer of Cidara Therapeutics, Inc. (CDTX).
Where is Cidara Therapeutics, Inc. headquartered?
Cidara Therapeutics, Inc. is headquartered in United States.
Does CDTX pay a dividend?
Cidara Therapeutics, Inc. (CDTX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CDTX go public?
Cidara Therapeutics, Inc. (CDTX) completed its initial public offering in 2015.